FdaApplication

ANDA 211043

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTEVA PHARMACEUTICALS USA INC
application_typeANDA
approval_date2022-05-03

Products (1)

ProductActive ingredientStrengthDosage form
ZILEUTONZILEUTON600MGTABLET, EXTENDED RELEASE;ORAL

1 product